Military use of tranexamic acid in combat trauma: Does it matter?

Journal of Trauma and Acute Care Surgery

Volumn 83, Issue 4, 2017, Pages 579-588

  Howard, Jeffrey T ^a,b   Stockinger, Zsolt T ^c,d   Cap, Andrew P ^a   Bailey, Jeffrey A ^e,f   Gross, Kirby R ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b Battlefield Health and Trauma Center for Human Integrative Physiology   (United States)

^c Joint Base San Antonio Fort Sam Houston ^*  (United States)

^d Bureau of Medicine and Surgery   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

combat casualty care; massive transfusion; Tranexamic acid

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARMY; ARTICLE; BATTLE INJURY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; YOUNG ADULT; MILITARY MEDICINE; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; WARFARE; WOUNDS AND INJURIES;

ADULT; ANTIFIBRINOLYTIC AGENTS; FEMALE; HUMANS; MALE; MILITARY MEDICINE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANEXAMIC ACID; TREATMENT OUTCOME; WARFARE; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 85020631224     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000001613     Document Type: Article

References (49)

1. Cap AP, Baer DG, Orman JA, Aden J, Ryan K, Blackbourne LH. Tranexamic acid for trauma patients: A critical review of the literature. J Trauma. 2011;71(1 Suppl):S9-S14.
2. Smit KM, Naudie DD, Ralley FE, Berta DM, Howard JL. One dose of tranexamic acid is safe and effective in revision knee arthroplasty. J Arthroplasty. 2013;28(8 Suppl):112-115.
3. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: A systematic review and metaanalysis. J Bone Joint Surg Br. 2011;93(12):1577-1585.
4. Fu DJ, Chen C, Guo L, Yang L. Use of intravenous tranexamic acid in total knee arthroplasty: A meta-analysis of randomized controlled trials. Chin J Traumatol. 2013;16(2):67-76.
5. Zhang Y, Fu X, LiuWX, Li YM,Ma XL, Li ZJ. Safety and efficacy of intraarticular injection of tranexamic acid in total knee arthroplasty. Orthopedics. 2014;37(9):775-782.
6. Duncan CM, Gillette BP, Jacob AK, Sierra RJ, Sanchez-Sotelo J, Smith HM. Venous thromboembolismandmortality associatedwith tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty. 2015;30(2):272-276.
7. Wei W, Wei B. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty. 2014;29(11):2113-2116.
8. Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty. 2013;28(8 Suppl):74-77.
9. Hourlier H, Fennema P. Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: A randomised clinical trial. Hip Int. 2014;24(1):63-68.
10. Georgiadis AG, Muh SJ, Silverton CD,Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty. 2013;28(Suppl 8):78-82.
11. Zhou XD, Tao LJ, Li J, Wu LD. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg. 2013;133(7):1017-1027.
12. Irisson E, Hemon Y, Pauly V, Parratte S, Argenson J, Kerbaul F. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg & Res. 2012;98(5):477-483.
13. Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry M, Umar M. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J Orthop Surg Res. 2011;6:22.
14. Li ZJ, Fu X, Xing D, Zhang HF, Zang JC, Ma XL. Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials. Eur Spine J. 2013;22(9):1950-1957.
15. Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: A prospective, randomized, double-blind, placebo-controlled study. Spine. 2008;33(24):2577-2580.
16. Farrokhi M, Kazemi A, Eftekharian H, Akbari K. Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: A randomized clinical trial. J Neurosurg Anesthesiol. 2011;23(4):290-296.
17. Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg. 2001;93(1):82-87.
18. Sethna N, Zurakowski D, Brustowicz R, Bacsik J, Sullivan L, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102(4):727-732.
19. Tsutsumimoto T, Shimogata M, Ohta H, Yui M, Yoda I, Misawa H. Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: A prospective randomized study. Spine. 2011;36(23):1913-1918.
20. Wong J, El Beheiry H, Rampersaud Y, Lewis S, Ahn H, De Silva Y, Abrishami A, Baig N,McBroom R, Chung F. Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg. 2008;107(5):1479-1486.
21. Endres S, Heinz M,Wilke A. Efficacy of tranexamic acid in reducing blood loss in posterior lumbar spine surgery for degenerative spinal stenosis with instability: A retrospective case control study. BMC Surg. 2011;11:29.
22. Henry D, Carless P, Moxey A, O'Connell D, Stokes B, Ferguson D, Ker K. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;16(3):1-208.
23. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
24. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096-1101.
25. Morrison JJ, Dubose JJ, Rasmussen TE, MidwinterMJ.Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg. 2012;147(2):113-119.
26. Petersen MR, Deddens JA. A comparison of two methods for estimating prevalence ratios. BMC Med Res Methodol. 2008;8:9.
27. Savu A, Liu Q, Yasui Y. Estimation of relative risk and prevalence ratio. Stat Med. 2010;29(22):2269-2281.
28. Thompson M, Myers J, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med. 1998;55:272-277.
29. Indrayan A. Medical Biostatistics. Atlanta, GA: Chapman & Hall; 2012.
30. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, MidwinterMJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148(3):218-225.
31. Valle E, Allen C, Van Haren R, Jouria J, Li H, Livingstone A, Namias N, Schulman C, Proctor K. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76(6):1373-1378.
32. Harvin JA, Peirce CA, Mims MM, Hudson JA, Podbielski JM, Wade CE, Holcomb JB, Cotton BA. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg. 2015; 78(5):905-909.
33. Moore EE, Moore HB, Gonzalez E, Chapman MP, Hansen KC, Sauaia A, Silliman CC, Banerjee A. Postinjury fibrinolysis shutdown: rationale for selective tranexamic acid. J Trauma Acute Care Surg. 2015;78(6 Suppl 1): S65-S69.
34. del Junco DJ, Fox EE, Camp EA, Rahbar MH, Holcomb JB. Seven deadly sins in trauma outcomes research: an epidemiologic post mortem for major causes of bias. J Trauma Acute Care Surg. 2013;75(1):S97-S103.
35. Austin P. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27(12):2037-2049.
36. Austin P. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399-424.
37. CaliendoM, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv. 2008;22(1):31-72.
38. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
39. Rosenbaum P, Rubin D. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39(1):33-38.
40. Rubin D, Thomas N. Combining propensity score matching with additional adjustments for prognostic covariates. J Am Stat Assoc. 2000;95(450): 573-858.
41. Austin P. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: A systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134(5):1128-1135.
42. Levesque L,Hanley J, Kezouh A, Suissa S. Problemof immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087.
43. Baker S,O'Neill B, HaddonW, LongW. The Injury Severity Score: amethod for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14(3):187-196.
44. Copes W, Sacco W, Champion H, Bain L. Progress in Characterising Anatomic Injury 33rd Annual Meeting of the Association for the Advancement of Automotive Medicine. Baltimore, MD: 1989.
45. Lin D,Wei L. The robust inference for the Cox Proportional HazardsModel. J Am Stat Assoc. 1989;84(408):1074-1078.
46. SAS Institute. SAS v9.2. Cary, NC: SAS Institute; 2011.
47. US Army Institute of Surgical Research and Joint Trauma System. JTS & CCAT Clinical Practice Guidelines 2014 [updated 24 NOV 2014]. Available from: http://www.usaisr.amedd.army.mil/clinical-practice-guidelines.html.
48. Sundström A, Seaman H, Kieler H, Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case-control study using the General Practice Research Database. BJOG. 2009;116(1):91-97.
49. Napolitano L. Prehospital tranexamic acid: what is the current evidence? Trauma Surg Acute Care Open. 2017;2(1):e000056.